GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region

Waleed A. Al-Dahi; Saeed H. Khalaf; Dalal A. AlRomaihi; Naji M. Alamuddin; Hessa M. Al Kandari; Doaa K. Abdalla; Hanan Y. Alfadehla; Amin A. Jayyousi; Mashhood A. Siddique; Usama A. AlAlami; Guruprasad C. Subbarao; Shashikanth J. Chetty; Jehan A. Abdulla

doi:10.15537/smj.2025.46.2.20240620

الاقتباسات

388

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Waleed, A. A., Saeed, H. K., Dalal, A. A., Naji, M. A., Hessa, M. A. K., Doaa, K. A., Hanan, Y. A., Amin, A. J., Mashhood, A. S., Usama, A. A., Guruprasad, C. S., Shashikanth, J. C., Jehan, A. A. (2025). GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region. Saudi Medical Journal. https://doi.org/10.15537/smj.2025.46.2.20240620

Al-Ghamdi, F.; Bakr, S. · 2023

استشهاد

827

Cardiovascular disease outcomes post COVID-19 in Saudi patients

Zahrani, K.; Al-Harbi, M. · 2024

استشهاد

531

Effectiveness of social skills training interventions for children with autism spectrum disorder

Fatimah S. Alahmari; Abdulhadi A. Alhabbad; Hussain A. Alshamrani; Mohammed A. A · 2025

استشهاد

434

Understanding artificial intelligence through the eyes of future nurses